Export 4 results:
Author Title Type [ Year(Desc)]
Filters: Author is Sorensen, James L  [Clear All Filters]
2012
L. R. Metsch, Feaster, D. J., Gooden, L., Matheson, T., Mandler, R. N., Haynes, L., Tross, S., Kyle, T., Gallup, D., Kosinski, A. S., Douaihy, A., Schackman, B. R., Das, M., Lindblad, R., Erickson, S., P Korthuis, T., Martino, S., Sorensen, J. L., Szapocznik, J., Walensky, R., Branson, B., and Colfax, G. N., “Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial.”, Am J Public Health, vol. 102, no. 6, pp. 1160-7, 2012.
2016
L. R. Metsch, Feaster, D. J., Gooden, L., Matheson, T., Stitzer, M., Das, M., Jain, M. K., Rodriguez, A. E., Armstrong, W. S., Lucas, G. M., Nijhawan, A. E., Drainoni, M. - L., Herrera, P., Vergara-Rodriguez, P., Jacobson, J. M., Mugavero, M. J., Sullivan, M., Daar, E. S., McMahon, D. K., Ferris, D. C., Lindblad, R., VanVeldhuisen, P., Oden, N., Castellón, P. C., Tross, S., Haynes, L. F., Douaihy, A., Sorensen, J. L., Metzger, D. S., Mandler, R. N., Colfax, G. N., and del Rio, C., “Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.”, JAMA, vol. 316, no. 2, pp. 156-70, 2016.
2017
P. T. Korthuis, Lum, P. J., Vergara-Rodriguez, P., Ahamad, K., Wood, E., Kunkel, L. E., Oden, N. L., Lindblad, R., Sorensen, J. L., Arenas, V., Ha, D., Mandler, R. N., and McCarty, D., “Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.”, Addiction, vol. 112, no. 6, pp. 1036-1044, 2017.
2022
T. P Korthuis, Cook, R. R., Lum, P. J., Waddell, E. Needham, Tookes, H., Vergara-Rodriguez, P., Kunkel, L. E., Lucas, G. M., Rodriguez, A. E., Bielavitz, S., Fanucchi, L. C., Hoffman, K. A., Bachrach, K., Payne, E. H., Collins, J. A., Matthews, A., Oden, N., Jacobs, P., Jelstrom, E., Sorensen, J. L., and McCarty, D., “HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial.”, Addiction, 2022.